Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy

Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent... Ann Hematol (2017) 96:1579–1581 DOI 10.1007/s00277-017-3050-6 LETTER TO THE EDITOR Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy 1 2 1 2 Estelle Balducci & Vanessa Nivaggioni & John Boudjarane & Lakhdar Bouriche & 3 2 1 4 4 Ilhem Rahal & Denis Bernot & Emilie Alazard & Nicolas Duployez & Nathalie Grardel & 2 1 3 5 Isabelle Arnoux & Marina Lafage-Pochitaloff & Gérard Michel & Bertrand Nadel & Marie Loosveld Received: 3 April 2017 /Accepted: 11 June 2017 /Published online: 20 June 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, day 8 to day 29 according to the RIALTO protocol. At day 28, We here report a case of B-acute lymphoblastic leukemia BM aspirate revealed monocytic blasts (Fig. 1b) positive for (ALL) with KMT2A rearrangement that underwent a lineage CD33 (low), CD65 and CD15 and negative for B lineage switch to acute monocytic leukemia following CD19-targeted markers (cCD79a, CD19, CD22, CD34) (Fig. 1d, yellow). therapy. A 15-year-old male patient presented with leukocyto- Review of flow cytometry analysis prior to blinatumomab sis (white blood cells, 210 × 10 /L, anemia (hemoglobin, treatment demonstrated no monocytic subclones (with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Hematology Springer Journals

Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy

Loading next page...
 
/lp/springer_journal/lineage-switch-from-b-acute-lymphoblastic-leukemia-to-acute-monocytic-cFPGANzkU0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Hematology; Oncology
ISSN
0939-5555
eISSN
1432-0584
D.O.I.
10.1007/s00277-017-3050-6
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial